Cancer drug is first therapy to emerge from 23andMe-GSK deal - STAT

Cancer drug is first therapy to emerge from 23andMe-GSK deal - STAT

STAT Plus: Cancer drug is the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration

By MATTHEW HERPER

ADOBE

GlaxoSmithKline is starting human trials of the first medicine, a cancer drug, to emerge from its collaboration with consumer genetics firm 23andMe.

READ MORE